Hot search: news  Board  Industrial  network  Packaging  European  fashion  TOM  China,  retailer 
 
Home > News > Market > Content

Telik Has Reported a Net Loss for The Third Quarter

increase font size  reduce font Add date: 2016-11-30  Hits:67
Core prompt: Clinical stage drug development company Telik has reported a net loss of $1.88m, or $0.78 per share, for the third quarter ended 30 September 2012 compared

Clinical stage drug development company Telik has reported a net loss of $1.88m, or $0.78 per share, for the third quarter ended 30 September 2012 compared to a net loss of $2.85m, or $1.58 per share, for the third quarter ended 30 September 2011.

Loss from operations for third quarter of 2012 was $1.88m compared to loss from operations of $2.85m for the third quarter of 2011.

The company reported a net loss of $6.20m, or $3.07 per share, for the nine months ended 30 September 2012 compared to a net loss of $9.52m, or $5.30 per share, for the nine months ended 30 September 2011.

Loss from operations of $6.21m was reported for the first nine months of 2012 compared to loss from operations of $9.55m for the first nine months of 2011.

 

 
 
[ NewsSearch ]  [ Send Fav ]  [ Share ]  [ Print ]  [ Send Report ]  [ Close ]

 
Total0bar [View All]  Related Comments

 
Photo Recommended
Recommend News
Click Rank
 
Home | Products | Suppliers | News | Tradeshow | Sitemap | Message | RSS Feed